_version_ 1783673565667655680
author Huber, Meret K.
Raichle, Claudia
Lingor, Paul
Synofzik, Matthis
Borgmann, Stefan
Erber, Johanna
Tometten, Lukas
Rimili, Wolfgang
Dolff, Sebastian
Wille, Kai
Knauss, Samuel
Piepel, Christiane
Lanznaster, Julia
Rieg, Siegbert
Prasser, Fabian
Pilgram, Lisa
Spottke, Annika
Klockgether, Thomas
Klein, Christine
Hopfner, Franziska
Höglinger, Günter U.
author_facet Huber, Meret K.
Raichle, Claudia
Lingor, Paul
Synofzik, Matthis
Borgmann, Stefan
Erber, Johanna
Tometten, Lukas
Rimili, Wolfgang
Dolff, Sebastian
Wille, Kai
Knauss, Samuel
Piepel, Christiane
Lanznaster, Julia
Rieg, Siegbert
Prasser, Fabian
Pilgram, Lisa
Spottke, Annika
Klockgether, Thomas
Klein, Christine
Hopfner, Franziska
Höglinger, Günter U.
author_sort Huber, Meret K.
collection PubMed
description
format Online
Article
Text
id pubmed-8014567
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-80145672021-04-01 Outcomes of SARS‐CoV‐2 Infections in Patients with Neurodegenerative Diseases in the LEOSS Cohort Huber, Meret K. Raichle, Claudia Lingor, Paul Synofzik, Matthis Borgmann, Stefan Erber, Johanna Tometten, Lukas Rimili, Wolfgang Dolff, Sebastian Wille, Kai Knauss, Samuel Piepel, Christiane Lanznaster, Julia Rieg, Siegbert Prasser, Fabian Pilgram, Lisa Spottke, Annika Klockgether, Thomas Klein, Christine Hopfner, Franziska Höglinger, Günter U. Mov Disord Special Series Articles John Wiley & Sons, Inc. 2021-02-27 2021-04 /pmc/articles/PMC8014567/ /pubmed/33638915 http://dx.doi.org/10.1002/mds.28554 Text en [The copyright line for this article was changed on 04 March 2021, after original online publication.]© 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Special Series Articles
Huber, Meret K.
Raichle, Claudia
Lingor, Paul
Synofzik, Matthis
Borgmann, Stefan
Erber, Johanna
Tometten, Lukas
Rimili, Wolfgang
Dolff, Sebastian
Wille, Kai
Knauss, Samuel
Piepel, Christiane
Lanznaster, Julia
Rieg, Siegbert
Prasser, Fabian
Pilgram, Lisa
Spottke, Annika
Klockgether, Thomas
Klein, Christine
Hopfner, Franziska
Höglinger, Günter U.
Outcomes of SARS‐CoV‐2 Infections in Patients with Neurodegenerative Diseases in the LEOSS Cohort
title Outcomes of SARS‐CoV‐2 Infections in Patients with Neurodegenerative Diseases in the LEOSS Cohort
title_full Outcomes of SARS‐CoV‐2 Infections in Patients with Neurodegenerative Diseases in the LEOSS Cohort
title_fullStr Outcomes of SARS‐CoV‐2 Infections in Patients with Neurodegenerative Diseases in the LEOSS Cohort
title_full_unstemmed Outcomes of SARS‐CoV‐2 Infections in Patients with Neurodegenerative Diseases in the LEOSS Cohort
title_short Outcomes of SARS‐CoV‐2 Infections in Patients with Neurodegenerative Diseases in the LEOSS Cohort
title_sort outcomes of sars‐cov‐2 infections in patients with neurodegenerative diseases in the leoss cohort
topic Special Series Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014567/
https://www.ncbi.nlm.nih.gov/pubmed/33638915
http://dx.doi.org/10.1002/mds.28554
work_keys_str_mv AT hubermeretk outcomesofsarscov2infectionsinpatientswithneurodegenerativediseasesintheleosscohort
AT raichleclaudia outcomesofsarscov2infectionsinpatientswithneurodegenerativediseasesintheleosscohort
AT lingorpaul outcomesofsarscov2infectionsinpatientswithneurodegenerativediseasesintheleosscohort
AT synofzikmatthis outcomesofsarscov2infectionsinpatientswithneurodegenerativediseasesintheleosscohort
AT borgmannstefan outcomesofsarscov2infectionsinpatientswithneurodegenerativediseasesintheleosscohort
AT erberjohanna outcomesofsarscov2infectionsinpatientswithneurodegenerativediseasesintheleosscohort
AT tomettenlukas outcomesofsarscov2infectionsinpatientswithneurodegenerativediseasesintheleosscohort
AT rimiliwolfgang outcomesofsarscov2infectionsinpatientswithneurodegenerativediseasesintheleosscohort
AT dolffsebastian outcomesofsarscov2infectionsinpatientswithneurodegenerativediseasesintheleosscohort
AT willekai outcomesofsarscov2infectionsinpatientswithneurodegenerativediseasesintheleosscohort
AT knausssamuel outcomesofsarscov2infectionsinpatientswithneurodegenerativediseasesintheleosscohort
AT piepelchristiane outcomesofsarscov2infectionsinpatientswithneurodegenerativediseasesintheleosscohort
AT lanznasterjulia outcomesofsarscov2infectionsinpatientswithneurodegenerativediseasesintheleosscohort
AT riegsiegbert outcomesofsarscov2infectionsinpatientswithneurodegenerativediseasesintheleosscohort
AT prasserfabian outcomesofsarscov2infectionsinpatientswithneurodegenerativediseasesintheleosscohort
AT pilgramlisa outcomesofsarscov2infectionsinpatientswithneurodegenerativediseasesintheleosscohort
AT spottkeannika outcomesofsarscov2infectionsinpatientswithneurodegenerativediseasesintheleosscohort
AT klockgetherthomas outcomesofsarscov2infectionsinpatientswithneurodegenerativediseasesintheleosscohort
AT kleinchristine outcomesofsarscov2infectionsinpatientswithneurodegenerativediseasesintheleosscohort
AT hopfnerfranziska outcomesofsarscov2infectionsinpatientswithneurodegenerativediseasesintheleosscohort
AT hoglingergunteru outcomesofsarscov2infectionsinpatientswithneurodegenerativediseasesintheleosscohort
AT outcomesofsarscov2infectionsinpatientswithneurodegenerativediseasesintheleosscohort